{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:38:50Z","timestamp":1793911130643,"version":"4.8.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.rmed.2026.109187","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:32:34Z","timestamp":1790922754000},"page":"109187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advances in prognostic assessment of idiopathic pulmonary fibrosis: From clinical-physiological parameters and molecular biomarkers to multimodal models"],"prefix":"10.1016","volume":"263","author":[{"given":"Yingshuo","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fugui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-3390","authenticated-orcid":false,"given":"Chunting","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.rmed.2026.109187_bib1","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109187_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1679011","article-title":"Changes in lung function and exercise capacity are strong predictors of mortality in patients with IPF receiving antifibrotic therapy","volume":"12","author":"Oh","year":"2025","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109187_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.chest.2025.02.018","article-title":"Changes in lung function and mortality risk in patients with idiopathic pulmonary fibrosis","volume":"168","author":"Oldham","year":"2025","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.rmed.2026.109187_bib4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1164\/rccm.2111053","article-title":"Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography","volume":"167","author":"Wells","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.109187_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S2213-2600(15)00096-X","article-title":"CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the fleischner society","volume":"3","author":"Hansell","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.109187_bib6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.201201-0006PP","article-title":"Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials","volume":"185","author":"Raghu","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109187_bib7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1183\/09031936.00131813","article-title":"6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis","volume":"43","author":"du Bois","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2026.109187_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02565-2024","article-title":"Development and validation of a predictive 6-min walk score in patients with idiopathic pulmonary fibrosis","volume":"66","author":"Nathan","year":"2025","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.109187_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201809-1652OC","article-title":"Imaging patterns are associated with interstitial lung abnormality progression and mortality","volume":"200","author":"Putman","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109187_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108488","article-title":"Upper-lobe subpleural irregularity predicts progression and mortality in idiopathic pulmonary fibrosis","volume":"249","author":"Oda","year":"2025","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109187_bib11","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.241001","article-title":"CT honeycombing and traction bronchiectasis extent independently predict survival across fibrotic interstitial lung disease subtypes","volume":"314","author":"Marinescu","year":"2025","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.rmed.2026.109187_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12127","article-title":"Clinical significance of pulmonary hypertension in interstitial lung disease: a consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension","volume":"12","author":"Nikkho","year":"2022","journal-title":"Pulm. Circ."},{"issue":"20","key":"10.1016\/j.rmed.2026.109187_bib13","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.3390\/jcm14207352","article-title":"Pulmonary hypertension drives prognosis in idiopathic pulmonary fibrosis: insights from the European IPF registry","volume":"14","author":"Guenther","year":"2025","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109187_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.chest.2019.04.003","article-title":"Imaging of pulmonary hypertension: pictorial essay","volume":"156","author":"Altschul","year":"2019","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2026.109187_bib15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1183\/09031936.00079512","article-title":"Pulmonary hypertension in COPD: results from the ASPIRE registry","volume":"41","author":"Hurdman","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmed.2026.109187_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201468","article-title":"Evaluation of the CT imaging findings in patients newly diagnosed with chronic thromboembolic pulmonary hypertension","volume":"13","author":"Grosse","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1164\/arrd.1986.133.1.97","article-title":"A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis","volume":"133","author":"Watters","year":"1986","journal-title":"Am. Rev. Respir. Dis."},{"issue":"7","key":"10.1016\/j.rmed.2026.109187_bib18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/ajrccm.164.7.2003140","article-title":"Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model","volume":"164","author":"King","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.109187_bib19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib20","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1038\/s41598-018-23073-3","article-title":"Comparison of CPI and GAP models in patients with idiopathic pulmonary fibrosis: a nationwide cohort study","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.rmed.2026.109187_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/thoraxjnl-2021-218440","article-title":"Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis","volume":"78","author":"Chandel","year":"2023","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.rmed.2026.109187_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1183\/23120541.00124-2023","article-title":"External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis","volume":"9","author":"Chandel","year":"2023","journal-title":"ERJ Open Res"},{"issue":"6","key":"10.1016\/j.rmed.2026.109187_bib23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm.164.6.2001056","article-title":"Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality","volume":"164","author":"King","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109187_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.humpath.2020.10.008","article-title":"Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis","volume":"107","author":"M\u00e4kel\u00e4","year":"2021","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1378\/chest.07-1948","article-title":"Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis","volume":"133","author":"Kinder","year":"2008","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1148\/rg.2020190099","article-title":"Quantitative CT analysis of diffuse lung disease","volume":"40","author":"Chen","year":"2020","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.ro.2018.12.007","article-title":"Quantitative CT of interstitial lung disease","volume":"54","author":"Newell","year":"2019","journal-title":"Semin. Roentgenol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109187_bib28","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00330-017-5053-z","article-title":"Serial automated quantitative CT analysis in idiopathic pulmonary fibrosis: functional correlations and comparison with changes in visual CT scores","volume":"28","author":"Jacob","year":"2018","journal-title":"Eur. Radiol."},{"issue":"5","key":"10.1016\/j.rmed.2026.109187_bib29","article-title":"Correlation of lung texture analysis by computer-aided lung informatics for pathology evaluation and rating (CALIPER) with high-resolution computed tomography and lung function in fibrosing interstitial lung diseases","volume":"18","author":"S","year":"2026","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.rmed.2026.109187_bib30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1513\/AnnalsATS.202101-044OC","article-title":"Novel artificial intelligence-based technology for chest computed tomography analysis of idiopathic pulmonary fibrosis","volume":"19","author":"Handa","year":"2022","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"7","key":"10.1016\/j.rmed.2026.109187_bib31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1164\/rccm.202112-2684OC","article-title":"Deep learning-based outcome prediction in progressive fibrotic lung disease using high-resolution computed tomography","volume":"206","author":"Walsh","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109187_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MCP.0000000000000978","article-title":"Exhaled breath analysis in interstitial lung disease","volume":"29","author":"van der Sar","year":"2023","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"Suppl. 64","key":"10.1016\/j.rmed.2026.109187_bib33","first-page":"727","article-title":"Exhaled volatile organiccompounds in idiopathic pulmonary fibrosisand disease progression","volume":"56","author":"ConalHayton","year":"2020","journal-title":"EuropeanRespiratory Journa"},{"issue":"2","key":"10.1016\/j.rmed.2026.109187_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pccm.2024.04.003","article-title":"Biomarkers in idiopathic pulmonary fibrosis: current insight and future direction","volume":"2","author":"Zheng","year":"2024","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12931-021-01923-5","article-title":"The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study","volume":"23","author":"Plantier","year":"2022","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.rmed.2026.109187_bib36","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.chest.2021.06.037","article-title":"Familial pulmonary fibrosis: genetic features and clinical implications","volume":"160","author":"Zhang","year":"2021","journal-title":"Chest"},{"issue":"28","key":"10.1016\/j.rmed.2026.109187_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.rmed.2026.109187_bib38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.chest.2019.03.030","article-title":"Lung transplant outcomes in patients with pulmonary fibrosis with telomere-related gene variants","volume":"156","author":"Swaminathan","year":"2019","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(22)00251-X","article-title":"Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study","volume":"11","author":"Allen","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109187_bib40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pulmoe.2020.11.005","article-title":"Telomere length across different UIP fibrotic-Interstitial Lung diseases: a prospective Greek case-control study","volume":"28","author":"Tomos","year":"2022","journal-title":"Pulmonology"},{"issue":"3","key":"10.1016\/j.rmed.2026.109187_bib41","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1164\/rccm.201809-1646OC","article-title":"Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis","volume":"200","author":"Newton","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.109187_bib42","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.3390\/biomedicines11102796","article-title":"Molecular and genetic biomarkers in idiopathic pulmonary fibrosis: where are we now","volume":"11","author":"Tomos","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.rmed.2026.109187_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S2213-2600(13)70045-6","article-title":"Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study","volume":"1","author":"Noth","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.109187_bib44","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1164\/rccm.201304-0760OC","article-title":"The toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis","volume":"188","author":"O'Dwyer","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109187_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/MCP.0000000000000289","article-title":"Pharmacogenetics and interstitial lung disease","volume":"22","author":"Oldham","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12931-021-01860-3","article-title":"Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis","volume":"22","author":"Sivakumar","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2026.109187_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2019.05.014","article-title":"Review: serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons","volume":"202","author":"Jee","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2026.109187_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745233","article-title":"KL-6 as an immunological biomarker predicts the severity, progression, acute exacerbation, and poor outcomes of interstitial lung disease: a systematic review and meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-22483-4","article-title":"Serum KL-6 as a biomarker to predict progression at one year in interstitial lung disease","volume":"15","author":"Bonella","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12890-021-01530-6","article-title":"Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2026.109187_bib51","article-title":"SP-A and SP-D: dual functioning immune molecules with antiviral and immunomodulatory properties","volume":"11","author":"Watson","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2026.109187_bib52","article-title":"Serum surfactant protein D as a significant biomarker for predicting occurrence, progression, acute exacerbation, and mortality in interstitial lung disease: a systematic review and meta-analysis","volume":"16","author":"He","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2026.109187_bib53","first-page":"323","article-title":"Serum biomarkers of pulmonary damage and risk for progression of rheumatoid arthritis-associated interstitial lung disease","volume":"52","author":"Chang","year":"2025","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109187_bib54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1183\/09031936.00110510","article-title":"Elevation of surfactant protein A in plasma and sputum in cigarette smokers","volume":"38","author":"Mazur","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.rmed.2026.109187_bib55","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.3390\/ijms22126255","article-title":"Molecular biomarkers in idiopathic pulmonary fibrosis: state of the art and future directions","volume":"22","author":"Stainer","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-2600(16)30421-0","article-title":"Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial","volume":"5","author":"Raghu","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109187_bib57","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01612-2021","article-title":"A systematic review of blood biomarkers with individual participant data meta-analysis of matrix metalloproteinase-7 in idiopathic pulmonary fibrosis","volume":"59","author":"Khan","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.109187_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pccm.2023.05.002","article-title":"TIMP-1 and its potential diagnostic and prognostic value in pulmonary diseases","volume":"1","author":"Almuntashiri","year":"2023","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1465-9921-6-57","article-title":"Expression of HSP47 in usual interstitial pneumonia and nonspecific interstitial pneumonia","volume":"6","author":"Kakugawa","year":"2005","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.rmed.2026.109187_bib60","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.semarthrit.2020.01.006","article-title":"Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: where do we stand","volume":"50","author":"Elhai","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.rmed.2026.109187_bib61","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.200808-1201OC","article-title":"Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis","volume":"179","author":"Prasse","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109187_bib62","article-title":"S100A12 as biomarker of disease severity and prognosis in patients with idiopathic pulmonary fibrosis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109187_bib63","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","article-title":"ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis","volume":"108","author":"Bui","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109187_bib64","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01181-2021","article-title":"Biomarker signatures for progressive idiopathic pulmonary fibrosis","volume":"59","author":"Clynick","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.109187_bib65","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/ijms24021275","article-title":"Endothelin-1 as a biomarker of idiopathic pulmonary fibrosis and interstitial lung disease associated with autoimmune diseases","volume":"24","author":"Pulito-Cueto","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.rmed.2026.109187_bib66","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1164\/rccm.202503-0610OC","article-title":"Associations of high attenuation area-related proteomic biomarkers with fibrotic or subpleural interstitial lung abnormalities","volume":"211","author":"Kim","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.rmed.2026.109187_bib67","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3390\/cells10071642","article-title":"Autophagy, apoptosis, the unfolded protein response, and lung function in idiopathic pulmonary fibrosis","volume":"10","author":"Sharma","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.rmed.2026.109187_bib68","doi-asserted-by":"crossref","first-page":"L493","DOI":"10.1152\/ajplung.00372.2017","article-title":"Autophagy and the unfolded protein response promote profibrotic effects of TGF-\u03b2(1) in human lung fibroblasts","volume":"314","author":"Ghavami","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib69","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1172\/JCI93560","article-title":"Endoplasmic reticulum stress in the pathogenesis of fibrotic disease","volume":"128","author":"Kropski","year":"2018","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.rmed.2026.109187_bib70","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/thorax-2024-221398","article-title":"Genetic-informed proteome-wide scan reveals potential causal plasma proteins for idiopathic pulmonary fibrosis","volume":"79","author":"Zhu","year":"2024","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2026.109187_bib71","article-title":"Identifying potential biomarkers of idiopathic pulmonary fibrosis through machine learning analysis","volume":"13","author":"Wu","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.rmed.2026.109187_bib72","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.resinv.2025.07.021","article-title":"Multi-modal machine learning classifier for idiopathic pulmonary fibrosis predicts mortality in interstitial lung diseases","volume":"63","author":"Callahan","year":"2025","journal-title":"Respir. Investig."},{"issue":"2","key":"10.1016\/j.rmed.2026.109187_bib73","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.chest.2025.08.034","article-title":"Developing and validation of a multimodal-based machine learning model for diagnosis of usual interstitial pneumonia: a prospective multicenter study","volume":"169","author":"Wang","year":"2026","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.rmed.2026.109187_bib74","article-title":"Radiomics-based artificial intelligence and machine learning approach for the diagnosis and prognosis of idiopathic pulmonary fibrosis: a systematic review","volume":"17","author":"Khalid","year":"2025","journal-title":"Cureus"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126005561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126005561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:17:05Z","timestamp":1793909825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126005561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":74,"alternative-id":["S0954611126005561"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109187","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in prognostic assessment of idiopathic pulmonary fibrosis: From clinical-physiological parameters and molecular biomarkers to multimodal models","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109187"}}